NEW YORK (GenomeWeb News) – The US Food and Drug Administration has approved Gen-Probe’s Procleix Ultrio assay to screen donated blood for hepatitis B, the company said Wednesday.
 
GenProbe said the FDA's approval triggers a $10 million milestone payment from the Novartis subsidiary Chiron, which is the test’s worldwide distributor.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.